Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

2 Aug 2017 07:00

RNS Number : 8057M
Barr(A.G.) PLC
02 August 2017
 

IMMEDIATE RELEASE 2 August 2017

 

A.G. BARR p.l.c. 

 

("A.G. BARR")

 

Trading Update 

 

Revenue up 8% and Group on track to meet full year profit expectations

 

A.G. BARR, which produces and markets some of the UK's leading drink brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a trading update in respect of the 26 weeks ended 29 July 2017.

 

We are pleased to report a strong first half sales performance supported by the continued success of last year's new product launches. Revenue for the 26 weeks ended 29 July 2017 is expected to be £136m, an increase of c.8% on the same period in the prior year (2016: £125.6m).

 

This strong sales performance was delivered against a market backdrop that saw value increase by 3.5% and volume by 2.1% (Source: IRI UK soft drinks market data from 29 January to 18 June 2017). 

 

In the first half we increased our investment in support of our innovation and brand growth activity. This, combined with slightly later than anticipated phasing of price increases and generally higher operating costs, including the effect of weaker sterling on input costs, had a moderate impact on margins during the period.

 

We are making good progress with our sugar reduction programme and are confident that we will meet the portfolio target communicated in March 2017. We expect this programme to be completed by the end of the financial year (January 2018) as the reformulated products are phased in across the next six months.

 

Outlook

 

While the wider economic environment continues to be uncertain, we have a clear strategy and a strong commercial plan in place, and we remain confident that we will deliver a full year financial performance in line with the Board's expectations.

 

Roger White, Chief Executive Officer, commented:

 

"We have delivered a good first half with strong sales growth supported by our successful innovation programme, particularly IRN-BRU XTRA, which has now been launched in England and Wales, and Rubicon Spring, which is gaining distribution across multiple channels. We are well positioned to deliver against our expectations across the balance of the year."

 

 

For more information, please contact:

 

A.G. BARR 01236 852400

Roger White, Chief Executive

Stuart Lorimer, Finance Director

Instinctif Partners 020 7457 2020

Matthew Smallwood

Justine Warren

 

Next update: Interim Results - 26 September 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUPARUPMGAG
Date   Source Headline
10th Feb 20253:59 pmRNSDirector/PDMR Shareholding - Replacement
10th Feb 20253:10 pmRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSTrading Update
20th Jan 202511:00 amRNSDirector Declaration
9th Jan 20254:42 pmRNSDirector/PDMR Shareholding
7th Jan 202511:44 amRNSNotice of Trading Update
17th Dec 20249:20 amRNSDirector Declaration
9th Dec 20241:50 pmRNSDirector/PDMR Shareholding
12th Nov 20241:35 pmRNSDirector/PDMR Shareholding
4th Nov 202410:54 amRNSDirector/PDMR Shareholding
9th Oct 202410:10 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSInterim Results
9th Sep 20241:03 pmRNSDirector/PDMR Shareholding
4th Sep 20249:08 amRNSDirector Declaration
20th Aug 20248:39 amRNSDirector/PDMR Shareholding
8th Aug 20241:10 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTrading Statement
8th Jul 202412:03 pmRNSDirector/PDMR Shareholding
4th Jul 202410:17 amRNSNotice of Results
1st Jul 20244:50 pmRNSDirector/PDMR Shareholding
21st Jun 20243:22 pmRNSDirector/PDMR Shareholding
10th Jun 20241:51 pmRNSDirector/PDMR Shareholding
10th Jun 20241:48 pmRNSDirector/PDMR Shareholding
4th Jun 20249:36 amRNSDirector/PDMR Shareholding
31st May 20241:54 pmRNSResult of AGM
9th May 202411:28 amRNSDirector/PDMR Shareholding
7th May 20249:06 amRNSDirector/PDMR Shareholding
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.